Evaluation of apoptotic cells and immunohistochemical detection of FAS, FAS-L, Bcl-2, Bax, p52 and c-Myc in the skin of patients with chronic venous leg ulcers

International Journal of Molecular Medicine

Volumn 22, Issue 4, 2008, Pages 497-505

  Heising, Susanna ^a   Giebel, Jürgen ^a   Ostrowitzki, Anna Lena ^a   Riedel, Franziska ^a   Haase, Hermann ^a   Sippel, Kirstin ^a   Jünger, Michael ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Apoptosis; Immunohistochemistry; Leg ulcer; Skin; Venous disease

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ACANTHOSIS; ADULT; AGED; APOPTOSIS; ARTICLE; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LASER DOPPLER FLOWMETRY; LEG; LEG ULCER; MALE; MICROANGIOPATHY; NICK END LABELING; OXYGEN TENSION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN BLOOD FLOW; SKIN DEFECT; THIGH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD GAS MONITORING, TRANSCUTANEOUS; CHRONIC DISEASE; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MYC; SKIN; TUMOR SUPPRESSOR PROTEIN P53; VARICOSE ULCER;

EID: 54049110382     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000048     Document Type: Article

References (34)

1. Kane CD and Greenhalgh DG: Expression and localization of p53 and bcl-2 in healing wounds in diabetic and non-diabetic mice. Wound Repair Regen 8: 45-58, 2000.
2. Galkowska H, Olszewsk WL, Wojewodzka U, et al: Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers. Surgery 134: 213-220, 2003.
3. Rai NK, Tripathi K, Sharma D, et al: Apoptosis: a basic physiologic process in wound healing. Int J Low Extrem. Wounds 4: 138-144, 2005.
4. Heroy Y, Kahle B, Idzko M, et al: Venous leg ulcers and apoptosis: a TIMP-3 mediated pathway? J Invest Dermatol 123: 1210-1212, 2004.
5. Andriessen MP, van Bergen BH, Spruijt KI, et al: Epidermal proliferation is not impaired in chronic venous ulcers. Acta Derm Venereol 75: 459-462, 1995.
6. Rabe E, Pannier-Fischer F, Bromen K, et al: Bonner Venenstudie der Deutschen Gesellschaft fOr Phlebologie. Epidemiologische Untersuchung zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten in der städtischen und läindlichen Wohnbevölkerang. Phlebologie 32: 1-14, 2003.
7. Wollina U, Abdel-Naser MB and Mani R: A review of the microcirculation in skin in patients with chronic venous insufficiency: the problem and the evidence available for therapeutic options. Int J Lower Extremety Wounds 5: 169-180, 2006.
8. Stücker M, Steinbrügge J, Memmel U, et al: Disturbed vasomotion in chronic venous insufficiency. J Vasc Surg 38: 522-527, 2003.
9. Jünger M, Steins A, Hahn M, et al: Microcirculatory dysfunction in chronic venous insufficiency. Microcirculation 7: S3-S12, 2000.
10. Weisfelner ME and Gottlieb AB: The role of apoptosis in human epidermal keratinocytes. J Drugs Dermatol 4: 385-391, 2003.
11. Haake AR and Polakowska RR: Cell death by apoptosis in epidermal biology. J Invest Dermatol 101: 107-112, 1993.
12. Teraki Y and Shiohara T: Apoptosis and the skin. Eur J Dermatol 9: 413-426, 1999.
13. Wehrli P, Viard I, Bullani R, Tschopp J and French LE: Death receptors in cutaneous biology and disease. J Invest Dermatol 115: 141-149, 2000.
14. Tomkova H, Fujimoto W and Arata J: Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur J Dermatol 8: 256-260, 1998.
15. Baliga BC and Kumar S: Role of Bcl-2 family of proteins in malignancy. Hematol Oncol 20: 63-74, 2002.
16. Gandarillas A and Watt FM: c-Myc promotes differentiation of human epidermal stem cells. Genes Dev 11: 2869-2882, 1997.
17. Waikel RL, Wang XJ and Roop DR: Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene 18: 4870-4878, 1999.
18. Lotti T and Benci M: Plasminogen activators, venous leg ulcers and reepithelialization. Int J Dermatol 34: 696-699, 1995.
19. Kistner RL, Eklof B and Masuda EM: Diagnosis of venous disease of the lower leg extremeties: the CEAP classification. Mayo Clin Proc 71: 338-345, 1996.
20. Jünger M, Hahn M, Klyscz T, et al: Influence of healing on the disturbed blood flow regulation in venous ulcers. VASA 25: 341-348, 1996.
21. Jünger M, Klyscz T, Hahn M, et al: Disturbed blood flow regulation in venous leg ulcers. Int J Microcirc 16: 259-265, 1996.
22. Bollinger A, Leu AJ, Hoffmann U, et al: Microvascular changes in venous disease: an update. Angiology 48: 27-32, 1997.
23. Hahn J, Jünger M, Friedrich B, et al: Cutaneous inflammation limited to the region of the ulcer in chronic venous insufficiency. VASA 26: 277-281, 1997.
24. Schmeller W, Roszinski S and Huesmann M: Tissue oxygenation and microcirculation in dermatoliposclerosis with different degrees of erythema at the margins of venous ulcers. A contribution to hypodermitis symptoms. VASA 26: 18-24, 1997.
25. Vanscheidt W, Laaff H, Weiss JM, et al: Immunohistochemical investigation of dermal capillaries in chronic venous insufficiency. Acta Derm Venereol 71: 17-19, 1991.
26. Takiwaki H: Transcutaneous Po2 and Pco2 measurement in dermatology. Acta Derm Venereol Suppl. 185: 21-25, 1994.
27. Stacey MC, Burnand KG, Bhogal BS, et al: Pericapillary fibrin deposits and skin hypoxia precede the changes of lipodermatosclerosis in limbs at increased risk of developing a venous ulcer. Cardiovasc Surg 8: 372-380, 2000.
28. Pascarella L, Schmid Schönbein GW and Bergan JJ: Microcirculation and venous ulcers: a review. Ann Vasc Surg 19: 921-927, 2005.
29. Gilhar A, Ullmann Y, Karry R, et al: Ageing of human epidermis. the role of apoptosis, Fas and telomerase. Br J Dermatol 150: 56-63, 2004.
30. Hussein MR, Al-Badaiwy ZH and Guirguis MN: Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol 31: 643-651, 2004.
31. Baran W, Szepietowski JC and Szybejko-Machaj G: Expression of p53 protein in psoriasis. Acta Dermatovenerol Alp Panonica Adriat 14: 79-83, 2005.
32. Guan DW, Ohshima T and Kondo T: Immunohistochemical study on fas and fas-ligand in skin wound healing. Histochem J 32: 85-91, 2000.
33. Boehm I: Apoptosis in physiological and pathological skin: implications for therapy. Curr Mol Med 6: 375-341, 2006.
34. Batinac T, Zamolo G. Hadzisejdic I, et al: Expression of Bcl-2 family proteins in psoriasis. Croat Med J 48: 319-326, 2007.